MedPath

The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

Not Applicable
Recruiting
Conditions
Pancreatic Disease
Delayed Gastric Emptying
Pancreatic Cancer
Interventions
Procedure: Standard Child reconstruction
Procedure: Braun anastomosis
Registration Number
NCT05709197
Lead Sponsor
Radboud University Medical Center
Brief Summary

The goal of this clinical trial (REMBRANDT) is to evaluate the effectiveness of adding an extra connection (i.e. 'Braun anastomosis') after standard reconstruction in pancreatic head resection in reducing the incidence of delayed gastric emptying.

Detailed Description

Rationale/hypothesis: The addition of Braun enteroenterostomy (BE) reduces the incidence of delayed gastric emptying (DGE) resulting in lower morbidity and healthcare costs after pancreatoduodenectomy.

Objective: To assess the effectiveness of adding BE in reducing DGE in patients undergoing open pancreatoduodenectomy.

Study design: A multicenter, patient and observer blinded, registry-based randomized controlled trial.

Study population: Patients undergoing an open pancreatoduodenectomy for all indications.

Intervention: Braun enteroenterostomy (BE), or Braun anastomosis, in addition to usual care.

Usual care/comparison: Pancreatoduodenectomy with standard Child reconstruction.

Main endpoints:

1. Incidence of DGE Grade B/C (according to International Study Group of Pancreatic Surgery (ISGPS)

2. Incidence of postoperative pancreatic fistulas (POPF) Grade B/C (according to ISGPS), anastomotic leak, complications, hospital length of stay, functional outcome at 12 months, in-hospital mortality, 30-day mortality, healthcare costs.

Sample size: 256 in total, 128 per arm

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients undergoing open pancreatoduodenectomy have an increased risk of postoperative complications such as DGE, POPF and anastomotic leak. The addition of BE, which is an anastomosis, could also result in a leak. However, this risk is diminishable compared to the risks of DGE and DGE related other complications like anastomotic leaks associated with standard pancreatoduodenectomy. Moreover, previous cohort studies involving BE do not describe an increased risk of adverse outcomes for BE.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
256
Inclusion Criteria
  • Undergoing open pancreatoduodenectomy
  • Provided informed consent
  • Age over 18 years
Exclusion Criteria
  • Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires in Dutch hospitals
  • Previous bariatric surgery (such as Roux-en-Y gastric bypass, gastric sleeve)
  • Pregnancy
  • Bowel motility disorders
  • Minimally invasive pancreatoduodenectomy
  • Gastric outlet syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Child reconstructionStandard Child reconstructionOpen pancreatoduodenectomy only
Braun anastomosisBraun anastomosisOpen pancreatoduodenectomy with Braun enteroenterostomy
Primary Outcome Measures
NameTimeMethod
Delayed gastric emptying (DGE)During hospitalization

DGE is defined by the need for maintenance of the nasogastric tube (NGT), need for reinsertion of NGT for persistent vomiting after postoperative day (POD) 7, or inability to tolerate a solid diet.

Secondary Outcome Measures
NameTimeMethod
Anastomotic leakDuring hospitalization

Anastomotic leaks of the hepatojejunostomy (HJ) or Braun enteroenterostomy (BE).

Anastomotic leaks of the HJ manifest as bile leakage. This is defined as "fluid with an increased bilirubin concentration in the abdominal drain or in the intra-abdominal fluid on or after postoperative day 3, or as the need for radiologic intervention because of biliary collections or relaparotomy resulting from bile peritonitis. Increased bilirubin in the drain is defined as bilirubin concentration more than 3 times greater than the serum bilirubin concentration.

An anastomotic leak of the BE is present when an abdominal CT with contrast shows leakage of contrast from the BE or when during relaparotomy dehiscence of the BE is apparent.

Quality of life (QoL) based on five dimensionsChange from baseline at 1 week, at 2 weeks, and 3 months

The EQ-5D-5L standardized questionnaire will be used.

Pancreatic fistula (POPF)During hospitalization

Any measurable volume of drain output with an amylase level of more than 3 times the upper limit of normal serum amylase and clinically relevant condition or development of the patient directly related to the POPF.

Number of days participants were hospitalizedDuring hospitalization

The time period in days between hospital admission and discharge from the hospital.

Participants perceived disease and treatment related quality of lifeChange from baseline at 2 weeks, 3 months, and 12 months

The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30/PAN26 standardized quality of life questionnaires will be used.

Functional outcome at 12 months12 months

Participants will be phoned to assess whether they have complaints of delayed gastric emptying ("afferent loop syndrome").

Postoperative complications: incidence and severityDuring hospitalization

Scored according to the modified Clavien-Dindo classification for surgical complications. Grade III and higher are considered clinically relevant in this study.

Number of participants with in-hospital mortalityDuring hospitalization

Any death during hospital admission.

30-day mortality30 days

Any death occurring 30 days after pancreatoduodenectomy.

Quality of recoveryChange from baseline at 1 week, at 2 weeks, and 3 months

The QoR-15 standardized questionnaire will be used.

Trial Locations

Locations (12)

LUMC

🇳🇱

Leiden, Netherlands

Groningen UMC

🇳🇱

Groningen, Netherlands

Maastricht UMC+

🇳🇱

Maastricht, Netherlands

St Antonius hospital

🇳🇱

Nieuwegein, Netherlands

Isala hospital

🇳🇱

Zwolle, Netherlands

OLVG

🇳🇱

Amsterdam, Netherlands

Erasmus MC

🇳🇱

Rotterdam, Netherlands

Amsterdam UMC

🇳🇱

Amsterdam, Netherlands

Medical spectrum Twente

🇳🇱

Enschede, Netherlands

Catharina hospital

🇳🇱

Eindhoven, Netherlands

Radboud UMC

🇳🇱

Nijmegen, Netherlands

Medical center Leeuwarden

🇳🇱

Leeuwarden, Netherlands

© Copyright 2025. All Rights Reserved by MedPath